A Closer Look at Study Design and Patient Demographics from the CheckMate 9ER Trial
Drs Choueiri and Gosain review study design, patient demographics, and clinical characteristics from the CheckMate 9ER trial, including prior nephrectomy and PD-L1 status.
EP: 1.Overview of ccRCC and Introduction to the CheckMate 9ER Trial
Now Viewing
EP: 2.A Closer Look at Study Design and Patient Demographics from the CheckMate 9ER Trial
EP: 3.CheckMate 9ER: Progression-free Survival, Overall Survival, and Objective
EP: 4.Adverse Events Following Use of Nivolumab Plus Cabozantinib in Patients With Advanced ccRCC
EP: 5.A Post-hoc Analysis of CheckMate 9ER Data and Study Conclusions
EP: 6.Clinical Insights Surrounding CheckMate 9ER Updates and Use of Nivolumab Plus Cabozantinib in ccRCC
EP: 7.Recap: Combination Therapy Shows Promise in Renal Cell Carcinoma
Related Videos
